Clinical Trials

Esophageal Squamous Cell Carcinoma

NCT07518147 2026-04-08

A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in Patients With Claudin (CLDN)18.2-Positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) Who Have Received Prior First-Line Treatment

438 enrolled

Stomach Neoplasms

NCT03801876 2026-04-03

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

300 enrolled

Clinical Stage I Esophageal Adenocarcinoma AJCC v8

NCT07463573 2026-03-11

QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma

466 enrolled

Esophageal Squamous Cell Carcinoma

NCT03221426 2026-03-09

KEYNOTE-585

1,007 enrolled 25 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Stomach Neoplasms

NCT06346392 2026-03-09

AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2

572 enrolled

Stomach Neoplasms

NCT04882241 2026-03-06

KEYNOTE-585

120 enrolled 17 charts

Phase 3 Active not recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Stomach Neoplasms

NCT06356311 2026-02-27

TroFuse-015

450 enrolled

Adenocarcinoma Of Esophagus

NCT07366528 2026-01-26

Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer

387 enrolled

Neoplasms, Stomach Neoplasms

NCT06644781 2026-01-12

A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

510 enrolled

Esophageal Squamous Cell Carcinoma

NCT06296706 2024-11-14

A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer

630 enrolled

Stomach Neoplasms

NCT02578368 2024-11-12

FLOT5

183 enrolled

Stomach Neoplasms

NCT04447352 2024-11-12

PREVENT

200 enrolled

Stomach Neoplasms

NCT03430843 2024-10-26

A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma

512 enrolled 27 charts

Esophageal Squamous Cell Carcinoma, Neoplasm Metastasis

NCT06492941 2024-07-09

A Study of Docetaxel for Injection (Albumin Bound) in Patients With Advanced Pancreatic Cancer

142 enrolled

Advanced Pancreatic Cancer

NCT06411171 2024-05-17

Safety and Efficacy of Pembrolizumab in Combination With FLOT About Gastroesophageal Junction Cancer:

36 enrolled

Phase 3 Active not recruiting

Gastroesophageal Junction Cancer

NCT02509286 2024-05-08

ESOPEC

438 enrolled

Adenocarcinoma Of Esophagus, Adenocarcinoma, Esophageal Neoplasms

NCT06194734 2024-03-07

A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal Cancer

490 enrolled

Esophageal Squamous Cell Carcinoma

NCT01935778 2024-02-28

Compare Adjuvant Chemotherapy of Docetaxel/Capecitabine/Oxliplatin Versus Capecitabine/Oxaliplatin in Advanced Gastric Cancer at Stage IIIb and IV(KCSG ST15-08): TRIUMPH

286 enrolled

Stomach Neoplasms

NCT03099382 2024-01-22

Study of SHR-1210 Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal Cancer

457 enrolled 9 charts

Esophageal Neoplasms

NCT02465736 2024-01-16

Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308)

610 enrolled

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT06123494 2024-01-16

SHR-A1811 for Subjects With Her2-positive Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on or After First-line Anti-HER2 Therapy-containing Regimen

360 enrolled

HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

NCT01515748 2023-12-13

PRODIGY

530 enrolled 11 charts

Stomach Neoplasms

NCT05264896 2023-09-07

Perioperative FLOT vs Adjuvant XELOX for CA Stomach

110 enrolled

Adenocarcinoma, Stomach Neoplasms

NCT05813015 2023-04-14

Study of Comparing of With and Without Sequential Therapy of S-1

70 enrolled

Locally Advanced Gastric Adenocarcinoma

NCT03933449 2023-03-29

KEYNOTE-181

123 enrolled 25 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Neoplasms

NCT02564263 2023-03-13

KEYNOTE-181

628 enrolled 27 charts 1 FDA

Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Neoplasms

NCT01726452 2022-09-30

NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS)

377 enrolled

Esophageal Neoplasms

NCT02569242 2022-07-06

Study of Nivolumab in Unresectable Advanced or Recurrent Esophageal Cancer

419 enrolled 20 charts 1 FDA

Esophageal Neoplasms

NCT03961867 2021-06-01

Docetaxel Versus Oxaliplatin as Addition to S-1 for Stage II / III Gastric Adenocarcinoma

440 enrolled

Stomach Neoplasms

NCT01107639 2020-10-20

Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery

297 enrolled

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT04351867 2020-07-16

A Clinical Trial of Two Adjuvant Chemotherapy Regimens for Postoperative Gastric Cancer

196 enrolled

Stomach Neoplasms

NCT02076594 2019-10-09

Low-Tox Vs Eox In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer

Phase 3 Terminated

171 enrolled

Stomach Neoplasms

NCT03061058 2017-09-15

Individualized Intraperitoneal and System Chemotherapy Versus System Chemotherapy as First-line Chemotherapy for AGC

240 enrolled

Stomach Neoplasms

NCT03067792 2017-03-01

FOLFIRI Versus Docetaxel and Cisplatin as a Second-line Chemotherapy After Failure of First-line Chemotherapy in Advanced Gastric Cancer

52 enrolled

Inoperable Gastric Cancer

NCT03002064 2016-12-26

Docetaxol Plus Cisplatin Versus 5-Fu Plus Cisplatin as 1st-line Chemotherapy in Advanced ESCC Patients

358 enrolled

Esophageal Neoplasms

NCT00978549 2013-08-07

Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer

320 enrolled

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Nausea, Pain, Stomach Neoplasms, Vomiting

NCT01283217 2013-06-04

Docetaxel and S1 (DS) Versus S1 and Cisplatin (SP) in Curatively Resected Stage IIIB/IV Gastric Cancer

166 enrolled

Gastric Adenocarcinoma

NCT00525200 2012-12-21

PANCHO

170 enrolled

Esophageal Neoplasms

NCT00811447 2012-08-31

Taxotere New Indication - Gastric Cancer Treatment Registration Trial

243 enrolled

Stomach Neoplasms

NCT00287768 2011-06-28

Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer

628 enrolled